#616781
Table of Contents
A number sign (#) is used with this entry because of evidence that Joubert syndrome-25 (JBTS25) is caused by homozygous or compound heterozygous mutation in the CEP104 gene (616690) on chromosome 1p36.
Joubert syndrome-25 is an autosomal recessive ciliopathy characterized by delayed psychomotor development and oculomotor apraxia associated with cerebellar hypoplasia manifest as the molar tooth sign on brain imaging. The clinical manifestations appear to be confined to the neurologic system, as patients tend not to have additional renal, liver, or limb involvement (summary by Srour et al., 2015)
For a phenotypic description and a discussion of genetic heterogeneity of Joubert syndrome, see 213300.
Srour et al. (2015) reported 3 unrelated children with Joubert syndrome. All had a neurologic form of the disorder characterized by significantly delayed psychomotor development, oculomotor apraxia, and the molar tooth sign on brain imaging. Two patients had hypotonia and ataxia, 1 had breathing abnormalities, and 1 had an abnormal electroretinogram. None had renal, liver, or limb abnormalities.
The transmission pattern of JBTS25 in the families reported by Srour et al. (2015) was consistent with autosomal recessive inheritance.
In 3 unrelated children with Joubert syndrome-25, Srour et al. (2015) identified homozygous or compound heterozygous mutations in the CEP104 gene (616690.0001-616690.0003). The mutations, which were found by exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the families. Functional studies and studies on patient cells were not performed.
Srour, M., Hamdan, F. F., McKnight, D., Davis, E., Mandel, H., Schwartzentruber, J., Martin, B., Patry, L., Nassif, C., Dionne-Laporte, A., Ospina, L. H., Lemyre, E., and 22 others. Joubert syndrome in French Canadians and identification of mutations in CEP104. Am. J. Hum. Genet. 97: 744-753, 2015. [PubMed: 26477546, images, related citations] [Full Text]
ORPHA: 475; DO: 0110994;
| Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
|---|---|---|---|---|---|---|
| 1p36.32 | Joubert syndrome 25 | 616781 | Autosomal recessive | 3 | CEP104 | 616690 |
A number sign (#) is used with this entry because of evidence that Joubert syndrome-25 (JBTS25) is caused by homozygous or compound heterozygous mutation in the CEP104 gene (616690) on chromosome 1p36.
Joubert syndrome-25 is an autosomal recessive ciliopathy characterized by delayed psychomotor development and oculomotor apraxia associated with cerebellar hypoplasia manifest as the molar tooth sign on brain imaging. The clinical manifestations appear to be confined to the neurologic system, as patients tend not to have additional renal, liver, or limb involvement (summary by Srour et al., 2015)
For a phenotypic description and a discussion of genetic heterogeneity of Joubert syndrome, see 213300.
Srour et al. (2015) reported 3 unrelated children with Joubert syndrome. All had a neurologic form of the disorder characterized by significantly delayed psychomotor development, oculomotor apraxia, and the molar tooth sign on brain imaging. Two patients had hypotonia and ataxia, 1 had breathing abnormalities, and 1 had an abnormal electroretinogram. None had renal, liver, or limb abnormalities.
The transmission pattern of JBTS25 in the families reported by Srour et al. (2015) was consistent with autosomal recessive inheritance.
In 3 unrelated children with Joubert syndrome-25, Srour et al. (2015) identified homozygous or compound heterozygous mutations in the CEP104 gene (616690.0001-616690.0003). The mutations, which were found by exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the families. Functional studies and studies on patient cells were not performed.
Srour, M., Hamdan, F. F., McKnight, D., Davis, E., Mandel, H., Schwartzentruber, J., Martin, B., Patry, L., Nassif, C., Dionne-Laporte, A., Ospina, L. H., Lemyre, E., and 22 others. Joubert syndrome in French Canadians and identification of mutations in CEP104. Am. J. Hum. Genet. 97: 744-753, 2015. [PubMed: 26477546] [Full Text: https://doi.org/10.1016/j.ajhg.2015.09.009]
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM